• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    AstraZeneca Pharma India Ltd.
    30 May 2025
    9064.50
    -0.40%
    AstraZeneca Pharma Q4 FY25 net profit jumps 48% to Rs 58.25 crore
    Business Standard
    Q4 net profit rises 48% to Rs 58.25 crore; revenue up 25.3% on strong growth across therapeutic areas, with oncology revenue up over 31% and record full-year sales
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above all available SMAs
    AstraZeneca Pharma rises 2% on securing CDSCO nod for Benralizumab solution
    Business Standard | 30 May 2025
    logo
    Natco Pharma Ltd.
    30 May 2025
    851.20
    1.18%
    Natco Pharma Q4 Results Review: Dolat Capital Maintains 'Sell', Sees 11% Downside
    Natco Pharma Q4 Results Review: Dolat Capital Maintains 'Sell', Sees 11% Downside
    NDTV Profit
    Dolat Capital maintains Sell' rating with a revised target price of Rs772 at 28x FY27E P/E.
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. has lost -44.95% in the last 1 Year
    logo
    Alkem Laboratories Ltd.
    30 May 2025
    5340.00
    0.07%
    Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?
    Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?
    Economic Times
    Alkem Laboratories shares fell 5% after Q4FY25 results showed a modest 4.2% profit rise to Rs 306 crore and margin contraction to 12.4%. While Jefferies downgraded the target to Rs 4,460 citing weak margins, Nomura maintained a Buy' with a Rs 5,430 target. The company expects high single-digit revenue growth in FY26 and rising tax rates in FY27.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
    Alkem Labs Q4 Review: Jefferies Cuts Estimates, Flags Execution Risks
    NDTV Profit | 30 May 2025
    logo
    Concord Biotech Ltd.
    30 May 2025
    1633.90
    3.26%
    Concord Biotech share price pops 6% on healthy Q4 nos; profit zooms 48% YoY
    Business Standard
    Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
    Copy LinkShare onShare on Share on Share on
    Concord Biotech Ltd. is trading below all available SMAs
    logo
    Wockhardt Ltd.
    29 May 2025
    1528.40
    2.32%
    Wockhardt Q4 results: Drug maker's net loss shrinks to Rs 45 crore
    Business Standard
    Drug firm Wockhardt on Thursday reported a consolidated net loss of Rs 45 crore in the fourth quarter ended March 31, 2025. The drug maker had reported a net loss of Rs 177 crore in the January-March quarter of FY24. Revenue from operations rose to Rs 743 crore in the fourth quarter as compared to Rs 700 crore in the year-ago period, Wockhardt said in a regulatory filing. For FY25, the company said its net loss stood at Rs 57 crore as compared to Rs 472 crore in the year-ago period. Revenue increased to Rs 3,012 crore as compared to Rs 2,798 crore in 2023-24 fiscal. Shares of the company closed at Rs 1,347.75 apiece, 0.63 per cent higher from previous close, on the BSE.
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd.'s price crossed above 200Day SMA today
    Wockhardt Q4 Results: Net Loss Narrows As Ebitda Turns Positive
    NDTV Profit | 29 May 2025
    logo
    Ipca Laboratories Ltd.
    29 May 2025
    1325.60
    0.42%
    Ipca Laboratories Q4 net profit up 14% at 68 crore
    Business Line
    The drug firm reported a net profit of 60 crore during the January-March quarter of 2023-24 financial year
    Copy LinkShare onShare on Share on Share on
    Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
    logo
    AstraZeneca Pharma India Ltd.
    29 May 2025
    9064.50
    -0.40%
    AstraZeneca gets CDSCO nod for lung cancer drug
    Business Line
    The company has received approval from the Central Drugs Standard Control Organisation, for Osimertinib tablets in strength of 40mg and 80mg, AstraZeneca India said in a statement
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. has gained 33.44% in the last 1 Year
    logo
    Natco Pharma Ltd.
    29 May 2025
    851.20
    1.18%
    Here's why Natco Pharma share price is buzzing in trade on Thursday, May 29
    Business Standard
    Natco Pharma share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. has an average target of 1297.50 from 4 brokers.
    Natco Pharma Q4 Results: Profit Misses Estimates, Margin Contracts; FY26 Outlook Gloomy
    NDTV Profit | 28 May 2025 1 more
    Natco Pharma's Q4 net up 4.9% at 406 cr
    Business Line | 28 May 2025
    logo
    Granules India Ltd.
    29 May 2025
    522.00
    -0.59%
    Granules India Q4 Review: Motilal Oswal Maintains 'Buy' Post Inline Results, But Cuts Target Price
    Granules India Q4 Review: Motilal Oswal Maintains 'Buy' Post Inline Results, But Cuts Target Price
    NDTV Profit
    Gagillapur remediation, Senn integration weigh on near-term profitability, says Motilal Oswal
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. has gained 18.76% in the last 1 Month
    Granules India Q4 results: Net profit jumps 17% to 152 cr
    Business Line | 28 May 2025
    logo
    Laurus Labs Ltd.
    27 May 2025
    896.85
    -0.60%
    Mahindra & Mahindra, Laurus Labs Check Shrikant Chouhan's Top Picks
    Mahindra & Mahindra, Laurus Labs Check Shrikant Chouhan's Top Picks
    NDTV Profit
    These recommendations come with specific target prices and stop-loss levels, providing clear guidance for potential investments.
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 34.39% in the last 3 Months
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd